A sweet spot in myeloid cell pro-tumoral functions
Immunity · 2025
DOI: 10.1016/j.immuni.2025.05.015 ↗Kurz gefasst
Kommentar in der Zeitschrift Immunity, 2025. Verfasst von Gillian Dunphy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. Electronic address: gillian.dunphy@cnic.es. Hauptthemen laut MEDLINE: Myeloid Cells, Neoplasms, Galectin 1, Neovascularization, Pathologic. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Gobierno de España Ministerio de Ciencia Innovación y Universidades, Agencia Estatal de Investigación.
Abstract (Originalsprache)
The regulation of myeloid cell responses can determine tumor outcomes. In this issue of Immunity, Blidner et al. report that galectin-1 triggers both immunoregulatory and pro-angiogenic circuits in myeloid cells, promoting tumor growth via a VEGF-dependent mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. Electronic address: gillian.dunphy@cnic.es.
- Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. Electronic address: dsancho@cnic.es.
Förderung
- Gobierno de España Ministerio de Ciencia Innovación y Universidades
- Agencia Estatal de Investigación
Zitieren
APA
Dunphy, G., & Sancho, D. (2025). A sweet spot in myeloid cell pro-tumoral functions. Immunity. https://doi.org/10.1016/j.immuni.2025.05.015
Vancouver
Dunphy G, Sancho D. A sweet spot in myeloid cell pro-tumoral functions. Immunity. 2025. doi:10.1016/j.immuni.2025.05.015
BibTeX
@article{Dunphy2025,
author = {Dunphy, Gillian and Sancho, David},
title = {A sweet spot in myeloid cell pro-tumoral functions},
journal = {Immunity},
year = {2025},
doi = {10.1016/j.immuni.2025.05.015}
}
EUVIMED